Watson Investigational Site 139 — Englewood, Ohio

Watson Investigational Site 139 is a clinical research site located in Englewood, Ohio, United States 45322.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Watson Investigational Site 139 has participated in 1 clinical trials.

Therapeutic areas: Leiomyoma, Uterine Hemorrhage.

Sponsors: Allergan.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Englewood

Browse all research sites in Ohio · View every site in Englewood

• Miami Valley Hospital North
• Hwc Women's Research Center
• Dayton Gastroenterology, Inc
• Englewood
• BioSante Site 160
• Research Site
• GSK Investigational Site
• Estetra Study Site
• Pfizer Investigational Site
• HWC Women's Research Center | Englewood, OH
• HWC Womens Research Center
• Synergy Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Watson Investigational Site 139?

Watson Investigational Site 139 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Watson Investigational Site 139 conducted?

Watson Investigational Site 139 has 1 clinical trials on record. Their work covers Leiomyoma, Uterine Hemorrhage.

Is Watson Investigational Site 139 accredited by Crixeo Clinical Trials?

Watson Investigational Site 139 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Watson Investigational Site 139?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.